Home › Funds › ADAR1 Capital Management, LLC › VKTX

ADAR1 Capital Management, LLC position in VKTX

VIKING THERAPEUTICS INC · Health Care

ADAR1 Capital Management, LLC reported holding 574,038 shares of VKTX (VIKING THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$22.4M, representing 1.24% of its reported portfolio and ranking #18 among its reported holdings. ADAR1 Capital Management, LLC has disclosed VKTX holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)574.04K sh
Reported value held$22.39M
Portfolio Weight1.24%
First reportedQ4 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How ADAR1 Capital Management, LLC's VKTX position evolved

ADAR1 Capital Management, LLC first disclosed a stake in VKTX in Q4 2023 at 254,151 shares (US$4.7M). The position peaked in Q2 2026 at 574,038 shares, worth US$22.4M. Across 11 filings, ADAR1 Capital Management, LLC increased the stake 7 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 574,038 shares valued at US$22.4M — an increase of 346,321 shares quarter over quarter.. Notable position changes include a 533% increase in Q2 2024 (shares rose 19% over the following quarter), a 539% increase in Q1 2025 (shares rose 10% over the following quarter), a 760% increase in Q1 2026 (shares rose 20% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 254.15K $4.73M New
Q1 2024 14.40K $1.18M Reduce
Q2 2024 91.23K $4.84M Add
Q3 2024 7.10K $449.50K Reduce
Q4 2024 9.30K $374.23K Add
Q1 2025 59.41K $1.43M Add
Q2 2025 67.81K $1.80M Add
Q3 2025 175.92K $4.62M Add
Q4 2025 26.49K $932.06K Reduce
Q1 2026 227.72K $7.41M Add
Q2 2026 574.04K $22.39M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VKTX and 13F data

VKTX (VIKING THERAPEUTICS INC) is a Health Care company. 34 other funds we track also report a position in VKTX — the largest reported positions include Vestal Point Capital, LP (US$26.5M), Eversept Partners, LP (US$23.5M), TANG CAPITAL MANAGEMENT LLC (US$19.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VKTX

All VKTX fund holders →

FAQ

How long has ADAR1 Capital Management, LLC held VKTX?

ADAR1 Capital Management, LLC has disclosed VKTX holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

What is ADAR1 Capital Management, LLC's current position in VKTX?

As of Q2 2026, ADAR1 Capital Management, LLC holds 574.04K shares of VKTX (VIKING THERAPEUTICS INC), valued at $22.39M, representing 1.24% of its reported portfolio and ranking #18.

Has ADAR1 Capital Management, LLC been buying or selling VKTX?

In the latest 13F filing (Q2 2026), ADAR1 Capital Management, LLC increased its position in VKTX. The position peaked in Q2 2026 at 574.04K shares.

Which other funds hold VKTX?

Other major institutional holders of VKTX include Vestal Point Capital, LP, Eversept Partners, LP, TANG CAPITAL MANAGEMENT LLC, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.